Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McGlave

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Hepatology (Baltimore, Md.)|January 1, 1984
Hepatic graft versus host disease: a study of the predictive value of liver biopsy in diagnosisD C Snover, S A Weisdorf, N K Ramsay, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1984
Empirical antibacterial therapy in febrile, granulocytopenic bone marrow transplant patientsP K Peterson, P McGlave, N K Ramsay, et al.
Human Pathology|April 1, 1985
A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantationD C Snover, S A Weisdorf, G M Vercellotti, et al.
Blood|January 15, 1993
Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor ProgramP McGlave, G Bartsch, C Anasetti, et al.
Transplantation|June 1, 1991
Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantationD Weisdorf, R Hakke, B Blazar, et al.
Transplantation|March 1, 1985
Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of antithymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host diseaseA H Filipovich, N K Ramsay, D C Arthur, et al.
Blood|February 15, 1990
Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcomeD Weisdorf, R Haake, B Blazar, et al.
Blood|July 1, 1992
Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficienciesA H Filipovich, R S Shapiro, N K Ramsay, et al.
Blood|April 15, 1992
Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotidesM Z Ratajczak, N Hijiya, L Catani, et al.
Transplantation|June 1, 1993
Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapyH Enright, R Haake, D Weisdorf, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Hepatology (Baltimore, Md.)|January 1, 1984
Hepatic graft versus host disease: a study of the predictive value of liver biopsy in diagnosisD C Snover, S A Weisdorf, N K Ramsay, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1984
Empirical antibacterial therapy in febrile, granulocytopenic bone marrow transplant patientsP K Peterson, P McGlave, N K Ramsay, et al.
Human Pathology|April 1, 1985
A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantationD C Snover, S A Weisdorf, G M Vercellotti, et al.
Blood|January 15, 1993
Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor ProgramP McGlave, G Bartsch, C Anasetti, et al.
Transplantation|June 1, 1991
Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantationD Weisdorf, R Hakke, B Blazar, et al.
Transplantation|March 1, 1985
Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of antithymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host diseaseA H Filipovich, N K Ramsay, D C Arthur, et al.
Blood|February 15, 1990
Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcomeD Weisdorf, R Haake, B Blazar, et al.
Blood|July 1, 1992
Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficienciesA H Filipovich, R S Shapiro, N K Ramsay, et al.
Blood|April 15, 1992
Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotidesM Z Ratajczak, N Hijiya, L Catani, et al.
Transplantation|June 1, 1993
Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapyH Enright, R Haake, D Weisdorf, et al.
Pageof 7